ArticleToxicology research2023

Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α-mediated mitochondrial biogenesis.

Meicong ChenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.